Jade Capital Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.42M Buy
70,000
+30,000
+75% +$613K 0.9% 39
2024
Q2
$903K Buy
40,000
+15,000
+60% +$393K 0.64% 52
2024
Q1
$657K Sell
25,000
-25,000
-50% -$712K 0.48% 59
2023
Q4
$1.58M Buy
50,000
+40,000
+400% +$1.09M 0.94% 39
2023
Q3
$281K Sell
10,000
-10,000
-50% -$343K 0.25% 63
2023
Q2
$738K Sell
20,000
-15,000
-43% -$458K 0.57% 50
2023
Q1
$1.05M Buy
+35,000
New +$1.15M 1.45% 26
2022
Q2
Sell
-49,453
Closed -$1.56M 40
2022
Q1
$1.56M Sell
49,453
-20,000
-29% -$626K 0.83% 42
2021
Q4
$1.95M Buy
69,453
+30,000
+76% +$935K 1.47% 23
2021
Q3
$1.15M Sell
39,453
-25,000
-39% -$809K 0.67% 45
2021
Q2
$2.24M Sell
64,453
-285,547
-82% -$9.46M 0.84% 41
2021
Q1
$9.77M Buy
350,000
+310,000
+775% +$8.25M 3.89% 3
2020
Q4
$992K Buy
+40,000
New +$952K 0.73% 40
2020
Q2
Sell
-30,000
Closed -$266K 66
2020
Q1
$266K Buy
30,000
+10,000
+50% +$144K 0.34% 49
2019
Q4
$362K Buy
+20,000
New +$332K 0.2% 71

Other funds holding CC

Jade Capital Advisors's CC Position: Q3 2024 in Review

Jade Capital Advisors increased its Chemours (CC) stake by 75% in Q3 2024, buying an estimated $613K and bringing the position to 70,000 shares worth $1.42M. The position accounts for 0.9% of the portfolio, ranked #39.

Jade Capital Advisors first reported a position in CC in Q4 2019 and has held it in 15 quarters since. The position peaked at $9.77M in Q1 2021. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Jade Capital Advisors held 70,000 shares of Chemours worth $1.42M as of Q3 2024.
  • Jade Capital Advisors bought 30,000 Chemours shares in Q3 2024, an estimated $613K.
  • Chemours made up 0.9% of Jade Capital Advisors's portfolio in Q3 2024, its #39 holding.
  • Jade Capital Advisors first reported a position in Chemours in Q4 2019 and has held it in 15 quarters since.
  • Jade Capital Advisors's Chemours position peaked at $9.77M in Q1 2021.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Jade Capital Advisors's 13F filing for Q3 2024, filed 21 Oct 2024.